Promotion of BRCA1-associated triple-negative breast cancer by ovarian hormones

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Current Opinion in Obstetrics and Gynecology

• Publication date

  2008-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/GCO.0b013e3282f42237PMID 18197009
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ubiquitin-Binding Protein RAP80 Mediates BRCA1-Dependent DNA Damage Response

  2007cited by this paper
• RAP80 Targets BRCA1 to Specific Ubiquitin Structures at DNA Damage Sites

  2007cited by this paper
• Abraxas and RAP80 Form a BRCA1 Protein Complex Required for the DNA Damage Response

  2007cited by this paper
• Estrogen receptor α is a putative substrate for the BRCA1 ubiquitin ligase

  2007cited by this paper
• Ten genes for inherited breast cancer.

  2007cited by this paper
• Cell signaling. A touching response to damage.

  2007cited by this paper
• Prophylactic oophorectomy in women at increased cancer risk

  2007cited by this paper
• The ubiquitin-interacting motif containing protein RAP80 interacts with BRCA1 and functions in DNA damage repair response.

  2007cited by this paper
• A role of estrogen/ERα signaling in BRCA1-associated tissue-specific tumor formation

  2007cited by this paper
• Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins

  2007cited by this paper
• E2–BRCA1 RING interactions dictate synthesis of mono- or specific polyubiquitin chain linkages

  2007cited by this paper
• BRCA1 Control of Steroid Receptor Ubiquitination

  2007cited by this paper
• A Touching Response to Damage

  2007cited by this paper
• Growth factor signaling pathways modulate BRCA1 repression of estrogen receptor-alpha activity.

  2007cited by this paper
• CCDC98 targets BRCA1 to DNA damage sites

  2007cited by this paper
• Estrogen receptor alpha is a putative substrate for the BRCA1 ubiquitin ligase.

  2007cited by this paper
• Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models

  2007cited by this paper
• Integration of rapid signaling events with steroid hormone receptor action in breast and prostate cancer.

  2007cited by this paper
• CCDC98 is a BRCA1-BRCT domain–binding protein involved in the DNA damage response

  2007cited by this paper
• SRC-3 coactivator functional lifetime is regulated by a phospho-dependent ubiquitin time clock.

  2007cited by this paper
• The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells.

  2006cited by this paper
• Squelching Progesterone's Signal May Prevent Breast Cancer

  2006cited by this paper
• Induction of progesterone target genes requires activation of Erk and Msk kinases and phosphorylation of histone H3.

  2006cited by this paper
• Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: An update

  2006cited by this paper
• Steroid receptor coactivator (SRC)-1 and SRC-3 differentially modulate tissue-specific activation functions of the progesterone receptor.

  2006cited by this paper
• BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP.

  2006cited by this paper
• Prevention of Brca1-Mediated Mammary Tumorigenesis in Mice by a Progesterone Antagonist

  2006cited by this paper
• Information networks in the mammary gland

  2005cited by this paper
• Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications.

  2005cited by this paper
• Depletion of BRCA1 impairs differentiation but enhances proliferation of mammary epithelial cells.

  2005cited by this paper
• Dynamic Cell Type Specificity of SRC-1 Coactivator in Modulating Uterine Progesterone Receptor Function in Mice

  2005cited by this paper
• Mammary developmental fate and breast cancer risk.

  2005cited by this paper
• Hallmarks of 'BRCAness' in sporadic cancers

  2004cited by this paper
• Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.

  2004cited by this paper
• BRCA1 functions as a breast stem cell regulator

  2004cited by this paper
• Prophylactic Bilateral Mastectomy for Breast Cancer Prevention

  2004cited by this paper
• The DNA double-strand break response pathway: becoming more BRCAish than ever.

  2004cited by this paper
• Repeated observation of breast tumor subtypes in independent gene expression data sets

  2003cited by this paper
• The BRCT Domain Is a Phospho-Protein Binding Domain

  2003cited by this paper
• The BRCA1/BARD1 Heterodimer Assembles Polyubiquitin Chains through an Unconventional Linkage Involving Lysine Residue K6 of Ubiquitin*

  2003cited by this paper
• Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

  2002cited by this paper
• Cancer Incidence in BRCA1 mutation carriers.

  2002cited by this paper
• The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans

  2002cited by this paper
• Autoubiquitination of the BRCA1·BARD1 RING Ubiquitin Ligase*

  2002cited by this paper
• BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor

  2001cited by this paper
• Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.

  2000cited by this paper
• Sequence-specific transcriptional corepressor function for BRCA1 through a novel zinc finger protein, ZBRK1.

  2000cited by this paper
• Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response.

  1999cited by this paper
• Identification of a RING protein that can interact in vivo with the BRCA1 gene product

  1996cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper

• Fertility Preservation in BRCA1/2 Germline Mutation Carriers: An Overview

  2024cites this paper
• Antiprogestins for breast cancer treatment: we are almost ready.

  2024cites this paper
• Overexpression of tripartite motif-containing 47 (TRIM47) confers sensitivity to PARP inhibition via ubiquitylation of BRCA1 in triple negative breast cancer cells

  2023cites this paper
• Selective progesterone receptor blockade prevents BRCA1-associated mouse mammary tumors through modulation of epithelial and stromal genes.

  2021cites this paper
• Fanconi Anemia Pathway: Mechanisms of Breast Cancer Predisposition Development and Potential Therapeutic Targets

  2020cites this paper
• BRCA1 and Breast Cancer: a Review of the Underlying Mechanisms Resulting in the Tissue-Specific Tumorigenesis in Mutation Carriers

  2019cites this paper
• Predictive macrosomia birthweight thresholds for adverse maternal and neonatal outcomes

  2016cites this paper
• Proliferation and ovarian hormone signaling are impaired in normal breast tissues from women with BRCA1 mutations: benefit of a progesterone receptor modulator treatment as a breast cancer preventive strategy in women with inherited BRCA1 mutations

  2016cites this paper
• Circulating estrogens and estrogens within the breast among postmenopausal BRCA1/2 mutation carriers

  2014cites this paper
• The effect of DASH diet on pregnancy outcomes in gestational diabetes: a randomized controlled clinical trial

  2014cites this paper
• Long-lasting effects of neonatal bisphenol A exposure on the implantation process.

  2014cites this paper
• SIMPLE: implementation of recommendations from international evidence-based guidelines on caesarean sections in the Netherlands. Protocol for a controlled before and after study

  2013cites this paper
• Familial breast cancer registry program in patients referred to the cancer institute of Iran.

  2012cites this paper
• Molecular characterization of some mutations in BRCA1 and BRCA2 genes of breast cancer patients

  2012influential citation
• Hidden costs associated with the universal application of risk management in maternity care.

  2011cites this paper
• Neonatal exposure to bisphenol A alters rat uterine implantation-associated gene expression and reduces the number of implantation sites.

  2011cites this paper
• Antitumor agents 279. Structure-activity relationship and in vivo studies of novel 2-(furan-2-yl)naphthalen-1-ol (FNO) analogs as potent and selective anti-breast cancer agents.

  2011cites this paper
• Mouse models of inherited cancer syndromes.

  2010cites this paper
• Oncogenes and tumor suppressor genes.

  2010cites this paper
• Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1.

  2010cites this paper
• Impact of Caesarean section on the future health of offspring

  2009cites this paper